|
LO-1
|
Will explain the anatomy of the upper respiratory tract. |
|
LO-2
|
Will explain the anatomy of the lower respiratory tract. |
|
LO-3
|
Will explain lung ventilation. |
|
LO-4
|
Will explain pulmonary circulation. |
|
LO-5
|
Will explain the physical principles of gas exchange. |
|
LO-6
|
Will explain the transport of oxygen and carbon dioxide in the blood and tissue fluids. |
|
LO-7
|
Will explain the regulation of respiration. |
|
LO-8
|
Will explain respiratory insufficiency. |
|
LO-9
|
Will explain the tumor cell. |
|
LO-10
|
Will explain tumor growth. |
|
LO-11
|
Will explain the formation of cancer. |
|
LO-12
|
Will explain the factors that influence cancer formation. |
|
LO-13
|
Will explain the treatment methods for cancer. |
|
LO-14
|
Will explain bacterial infections. |
|
LO-15
|
Will explain viral infections. |
|
LO-16
|
Explains parasitic infections. |
|
LO-17
|
Explains the basics of chemotherapy. |
|
LO-18
|
Will explain beta-lactam antibiotics. |
|
LO-19
|
Will explain macrolide, lincosamide, streptogramin antibiotics, and linezolid. |
|
LO-20
|
Will classify tetracyclines. |
|
LO-21
|
Will explain amphenicols. |
|
LO-22
|
Will explain aminoglycosides. |
|
LO-23
|
Will explain narrow-spectrum antibiotics. |
|
LO-24
|
Will explain fluoroquinolones. |
|
LO-25
|
Describes the mechanisms of action of fluoroquinolones. |
|
LO-26
|
Differentiates the indications of fluoroquinolones. |
|
LO-27
|
Will explain sulfonamides, co-trimoxazole, and trimethoprim. |
|
LO-28
|
Differentiates the indications of sulfonamides. |
|
LO-29
|
Explains the pharmacokinetic properties of trimethoprim. |
|
LO-30
|
Will explain the medications used in the treatment of urinary infections. |
|
LO-31
|
Will explain the medications used in the treatment of tuberculosis and other mycobacterial infections. |
|
LO-32
|
Will explain the antimicrobial and antiprotozoal medications. |
|
LO-33
|
Will explain the antimalarial medications. |
|
LO-34
|
Will explain the antihelminthic medications. |
|
LO-35
|
Will explain the medications used against ectoparasites. |
|
LO-36
|
Will explain the antiviral medications. |
|
LO-37
|
Will explain antiseptics and disinfectants. |
|
LO-38
|
Will explain the basic information and concepts related to cancer chemotherapy. |
|
LO-39
|
Will explain hormones and hormone antagonists. |
|
LO-40
|
Will explain other approaches used in cancer treatment. |
|
LO-41
|
Will explain antitussive medications. |
|
LO-42
|
Classifies antitussive medications. |
|
LO-43
|
Explains the contraindications of antitussive medications. |
|
LO-44
|
Will explain expectorants. |
|
LO-45
|
Classifies expectorant medications. |
|
LO-46
|
Explains the mechanisms of action of expectorant medications. |
|
LO-47
|
Will explain mucolytic medications. |
|
LO-48
|
Will explain surfactants. |
|
LO-49
|
Will explain bronchodilator medications and other anti-asthmatic drugs. |
|
LO-50
|
Will explain oxygen and other therapeutic gases. |
|
LO-51
|
Will explain the adverse effects induced by penicillins. |
|
LO-52
|
Will explain the adverse effects induced by cephalosporins. |
|
LO-53
|
Will explain the adverse effects induced by other beta-lactam antibiotics. |
|
LO-54
|
Will explain the adverse effects induced by macrolides. |
|
LO-55
|
Explains the mechanism of the adverse effects induced by macrolides. |
|
LO-56
|
Will explain the adverse effects induced by tetracyclines. |
|
LO-57
|
Will explain the adverse effects induced by amphenicols. |
|
LO-58
|
Will explain the adverse effects induced by aminoglycosides. |
|
LO-59
|
Will explain the adverse effects induced by narrow-spectrum antibiotics. |
|
LO-60
|
Will explain the adverse effects induced by fluoroquinolones. |
|
LO-61
|
Will explain the adverse effects induced by sulfonamides, co-trimoxazole, and trimethoprim. |
|
LO-62
|
Will explain the adverse effects induced by antifungal drugs. |
|
LO-63
|
Will explain the adverse effects induced by drugs used in tuberculosis and other mycobacterial infections. |
|
LO-64
|
Will explain the adverse effects induced by drugs used in the treatment of urinary infections. |
|
LO-65
|
Will explain the adverse effects induced by antiamoebic drugs. |
|
LO-66
|
Will explain the adverse effects induced by antimalarial drugs. |
|
LO-67
|
Will explain the adverse effects induced by anthelmintic drugs. |
|
LO-68
|
Will explain the adverse effects induced by drugs used against ectoparasites. |
|
LO-69
|
Will explain the adverse effects induced by antiviral drugs. |
|
LO-70
|
Will explain the adverse effects induced by antiseptics and disinfectants. |
|
LO-71
|
Will explain the adverse effects induced by cytotoxic drugs. |
|
LO-72
|
Will explain the adverse effects induced by hormones and hormone antagonists. |
|
LO-73
|
Will explain the adverse effects induced by antitussives, expectorants, mucolytic drugs, and surfactants. |
|
LO-74
|
Will explain the adverse effects induced by bronchodilators and other anti-asthmatic drugs. |